Hematopoietic stem cell transplantation is a life-saving therapy for many patients with
cancer, as well as patients with some nonmalignant hematologic disorders, such as aplastic …

Background While acute kidney injury (AKI) is commonly reported following hematopoietic
stem cell transplant (HCT), the incidence and impact of AKI on mortality among patients …

Hematopoietic stem cell transplantation (HSCT) is a highly effective treatment strategy for
lymphoproliferative disorders and bone marrow failure states including aplastic anemia and …

Hematopoietic cell transplantation is becoming an increasingly common treatment modality
for a variety of diseases. However, patient survival may be limited by substantial treatment …

Acute kidney injury (AKI) is a common complication after allogeneic stem cell
transplantation; however, its incidence and outcome in patients transplanted for multiple …

Acute kidney injury (AKI) is a common complication in haematopoietic cell transplantation
(HCT) patients and it adversely affects outcome. Herein, we provide a comprehensive and …

Over the last three decades, advancements in the diagnosis, treatment, and supportive care
of patients with cancer have significantly improved their overall survival. However, these …

Acute renal failure (ARF) after myeloablative stem cell transplantation (SCT) is a well-
established problem. Little is known about ARF after nonmyeloablative SCT. The aim of the …

Acute kidney injury (AKI) is highly prevalent whether the patients undergo myeloablative or
non-myeloablative hematopoietic cell transplantation (HCT); however, the pathogenesis and …

Over the past 2 decades, significant research and advancements have been made in
oncology and its therapeutics. Thanks to novel diagnostic methods, treatments, and …